Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Do Not Sell any assets...

    Do Not Sell any assets without Permission: Delhi HC to Singh Brothers

    Written by savita thakur thakur Published On 2017-03-08T11:14:53+05:30  |  Updated On 8 March 2017 11:14 AM IST
    Do Not Sell any assets without Permission: Delhi HC to Singh Brothers

    New Delhi: Post the Daiichi application in the Delhi High Court to stop the ex-Ranbaxy's owners Malvinder and Shivinder Singh to sale their any of stakes, the Court has now directed the two brother to seek the permission of the Delhi High Court before to sale of their assets.


    Meanwhile, as per the Daiichi's application to the court, the court has also directed the Singh brother to submit the details of all unencumbered assets, as in its last application, Daiichi requested to Delhi high to asked the Singh brothers to disclose their worth of holdings . The Japanese company has shown concern whether the owners have enough amount or not to pay Rs. 2600 crore to Daiichi or not.


    Medical Dialogues earlier reported that Japanese Company Daiichi Sankyo filed an application in the Court in order to block the former Ranbaxy owners Malvinder and Shivinder Singh’s to sell any of their stakes in Fortis Healthcare and allied subsidiaries.In the last application of Daiichi to Delhi High Court, Daiichi has also alleged that the Singh brothers have not obeyed the court’s order as it had directed them to submit the details of their assets value that can be considered during the award’s enforcement trial. The pharma company alleged that affidavit filed by the brothers is “not in terms” and “inconsistent with the court order and that they have failed to provide assurance that the assets, to the extent of the award amount, will remain and won’t be alienated until the award is enforced The Singh brothers on the other hand have denied the fact by saying that they have followed the court order.


    Read also: Daiichi again moves to Court to Block Fortis Stake Sale


    Justice Muralidhar in his order said, “It is clarified that the purpose of this direction is to ascertain how much of the assets of (the respondents) are realisable towards satisfaction of the decretal amount, as and when that stage arises."


    “Both Dr Singhvi and Mr Nayar state that if any change is proposed in the status of any of the unencumbered assets whose details are to be furnished... the respondents will first apply to the court,” the order said.


    The court has also directed the chartered accountants for the respondents to furnish within 10 days certificates giving the value of all unencumbered assets of Oscar Investments and RHC Holdings, the holding company of the Singh Brothers, reports ET


    To read the full story about the court proceedings on this issue, click on the ET story


    Ranbaxy's Singh brothers must seek permission to sell assets: High Court

    daiichiDelhi high courtFortisMalvinder SinghPermissionRanbaxyShinvder Singh
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok